C.Difficile Observational Study
NCT06277999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2025-12-19
Summary
D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring episodes of diarrhea and will need to complete validated PROs and study evaluation questionnaires
Conditions
- Clostridium Infections
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 130 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-22
- Primary Completion
- 2024-12-17
- Completion
- 2024-12-17
Countries
- United States
Study Locations
More Related Trials
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
NCT00446355 ·Status: COMPLETED
-
IMT for Primary Clostridium Difficile Infection
NCT02301000 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
NCT01232595 ·Status: COMPLETED ·Phase: PHASE2
-
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
NCT03586206 ·Status: UNKNOWN
-
Clostridioides Difficile Colonisation
NCT05693077 ·Status: RECRUITING ·Phase: PHASE1
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT02223715 ·Status: COMPLETED
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.
NCT03937999 ·Status: TERMINATED ·Phase: PHASE4
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800 ·Status: NOT_YET_RECRUITING
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02052726 ·Status: COMPLETED ·Phase: PHASE1
-
Natural History of Clostridioides Difficile Infection
NCT04801862 ·Status: RECRUITING
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
NCT01887912 ·Status: TERMINATED ·Phase: PHASE3
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
NCT04026009 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
NCT02200328 ·Status: TERMINATED ·Phase: PHASE4